
StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.?
With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, with the goal of reshoring drug production by American biopharmas, industry leaders, market watchers, and others have begun assessing which …